placeholder image
R. 艩别辫补谤辞惫颈膰 All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. 
    Lancet Oncology. 2017
    • Contact
    full name
  • R. 艩别辫补谤辞惫颈膰
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration